Insider Trading activities of Advancis Pharmaceutical Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Advancis Pharmaceutical Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Advancis Pharmaceutical Corp since year 2005. Table 2 shows the detailed insider transactions of Advancis Pharmaceutical Corp since 2005. The reporting company's ticker symbol is AVNC. The reporting company's CIK number is 1161924.
The total value of stock buying since 2005 is $23,542,252.
The total value of stock sales since 2005 is $757,017.
The total value of stock option exercises since 2005 is $140,645.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Advancis Pharmaceutical Corp (AVNC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2010-12 0 $0 19,900 $1,572 0 $0
2009-12 2,000,000 $830,000 0 $0 0 $0
2007-11 0 $0 40,000 $45,625 0 $0
2007-10 0 $0 40,000 $60,147 0 $0
2007-09 0 $0 40,000 $89,483 0 $0
2007-08 0 $0 40,000 $93,741 0 $0
2007-04 3,682,903 $8,702,699 0 $0 0 $0
2006-11 0 $0 10,000 $40,679 20,490 $28,890
2006-09 0 $0 40,000 $224,360 0 $0
2006-02 5,300 $9,545 110,000 $201,410 221,299 $111,755
2005-04 3,517,590 $14,000,008 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Advancis Pharmaceutical Corp insiders (AVNC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-12-06 Cole Brad (SVP, GC) Sale 19,900 .08 1,572
2009-12-17 Chai Trust Co Llc (10% Owner) Buy 2,000,000 .42 830,000
2007-11-26 Rudnic Edward M (President and CEO) Sale 11,400 1.10 12,597
2007-11-23 Rudnic Edward M (President and CEO) Sale 2,400 1.04 2,508
2007-11-21 Rudnic Edward M (President and CEO) Sale 4,300 1.09 4,687
2007-11-20 Rudnic Edward M (President and CEO) Sale 5,000 1.15 5,729
2007-11-19 Rudnic Edward M (President and CEO) Sale 10,200 1.18 12,036
2007-11-16 Rudnic Edward M (President and CEO) Sale 1,300 1.18 1,534
2007-11-15 Rudnic Edward M (President and CEO) Sale 5,400 1.21 6,534
2007-10-18 Rudnic Edward M (President and CEO) Sale 12,600 1.43 18,018
2007-10-17 Rudnic Edward M (President and CEO) Sale 10,700 1.49 15,943
2007-10-16 Rudnic Edward M (President and CEO) Sale 9,000 1.54 13,905
2007-10-15 Rudnic Edward M (President and CEO) Sale 7,700 1.60 12,281
2007-09-18 Rudnic Edward M (President and CEO) Sale 26,900 2.24 60,336
2007-09-17 Rudnic Edward M (President and CEO) Sale 13,100 2.22 29,147
2007-08-24 Rudnic Edward M (President and CEO) Sale 13,000 2.30 29,899
2007-08-23 Rudnic Edward M (President and CEO) Sale 11,000 2.36 25,938
2007-08-22 Rudnic Edward M (President and CEO) Sale 16,000 2.37 37,904
2007-04-12 Aguiar Eric (10% Owner) Buy 682,903 2.36 1,613,699
2007-04-12 Leschly Mark Buy 1,200,000 2.36 2,835,600
2007-04-12 Werner Harold R (Director) Buy 900,000 2.36 2,126,700
2007-04-12 Cavanaugh James H (Director) Buy 900,000 2.36 2,126,700
2006-11-21 Rudnic Edward M (President and CEO) Sale 10,000 4.07 40,679
2006-11-10 Low Robert C (Vice President & CFO) Option Ex 20,490 1.41 28,890
2006-09-20 Rudnic Edward M (President and CEO) Sale 40,000 5.61 224,360
2006-02-24 Low Robert C (Vice President & Acting CFO) Buy 5,300 1.80 9,545
2006-02-16 Rudnic Edward M (President and CEO) Sale 110,000 1.83 201,410
2006-02-16 Rudnic Edward M (President and CEO) Option Ex 221,299 .50 111,755
2005-04-29 Werner Harold R (Director) Buy 1,758,795 3.98 7,000,004
2005-04-29 Cavanaugh James H (Director) Buy 1,758,795 3.98 7,000,004

Insider trading activities including stock purchases, stock sales, and option exercises of AVNC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Advancis Pharmaceutical Corp (symbol AVNC, CIK number 1161924) see the Securities and Exchange Commission (SEC) website.